Project Details
Description
Prosensa-An open-label extension study of the long-term safety, tolerability and efficacy of drisapersen in US and Canadian subjects with Duchenne Muscular Dystrophy.
| Status | Finished |
|---|---|
| Effective start/end date | 9/1/14 → 10/30/16 |
Funding
- PROSENSA
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.